0001104659-17-047846.txt : 20170728 0001104659-17-047846.hdr.sgml : 20170728 20170728190051 ACCESSION NUMBER: 0001104659-17-047846 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170728 FILED AS OF DATE: 20170728 DATE AS OF CHANGE: 20170728 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Charles Scott J CENTRAL INDEX KEY: 0001649483 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37691 FILM NUMBER: 17991229 MAIL ADDRESS: STREET 1: 1414 RALEIGH ROAD, SUITE 400 STREET 2: SUITE 400 CITY: CHAPEL HILL STATE: NC ZIP: 27517 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aralez Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001660719 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7100 WEST CREDIT AVENUE, SUITE 101 CITY: MISSISSAUGA STATE: A6 ZIP: L5N 0E4 BUSINESS PHONE: 905-876-1118 MAIL ADDRESS: STREET 1: 7100 WEST CREDIT AVENUE, SUITE 101 CITY: MISSISSAUGA STATE: A6 ZIP: L5N 0E4 4 1 a4.xml 4 X0306 4 2017-07-28 0 0001660719 Aralez Pharmaceuticals Inc. ARLZ 0001649483 Charles Scott J C/O ARALEZ PHARMACEUTICALS INC., 7100 WEST CREDIT AVENUE, SUITE 101 MISSISSAUGA A6 L5N 0E4 ONTARIO, CANADA 0 1 0 0 Chief Financial Officer Common Shares, without par value 2017-07-28 4 S 0 10804 1.2504 D 280551 D This represents shares sold by the issuer on behalf of the reporting person pursuant to an instruction made in accordance with Rule 10b5-1 for payment of withholding tax liability incurred upon the vesting of 29,000 restricted stock units, which vested on July 27, 2017. 7,284 of such restricted stock units were previously granted on July 27, 2015 and 21,716 of such restricted stock units were previously granted on February 12, 2016. /s/ Eric L. Trachtenberg, attorney-in-fact for Scott J. Charles 2017-07-28